Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: Colitis suppression by a selective agonist, ONO-AE1-329

Scandinavian Journal of Immunology

Volumn 56, Issue 1, 2002, Pages 66-75

  Nitta, M ^a   Hirata, I ^a   Toshina, K ^a   Murano, M ^a   Maemura, K ^a   Hamamoto, N ^a   Sasaki, S ^a   Yamauchi, H ^a   Katsu, K ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AE 1 329; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; DEXTRAN SULFATE; GENE PRODUCT; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; DRUG SELECTIVITY; ENTERITIS; FECES ANALYSIS; HISTOPATHOLOGY; LEUKOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH EROSION; STOMACH ULCER; TISSUE LEVEL; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ACUTE DISEASE; ANIMALS; ANTI-ULCER AGENTS; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; CHO CELLS; COLITIS; COLON; CRICETINAE; DEXTRAN SULFATE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GROWTH SUBSTANCES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1; INTERLEUKIN-10; LEUKOCYTE COUNT; MALE; METHYL ETHERS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER; TIME FACTORS;

EID: 0036422957     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01096.x     Document Type: Article

References (48)

1. Stevens C, Walz G, Singaram C et al. Tumor necrosis factoralpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818-26.
2. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg 1998;22:382-9.
3. Gould SR. Letter: Prostaglandins, ulcerative colitis, and sulphasalazine. Lancet 1975;2:988.
4. Robert A, Nezamiks JE, Lancaster C et al. Prevention, through cytoprotection, of clindamycin-induced colitis in hamsters with 16,16-demetyl PGE2. Gastroenterology 1980;78:1245.
5. McCafferty DM, Zeitlin IJ. Inhibition of Butyric Acid-Induced Colitis in Mice by 16,16-Dimethyl Prostaglandin E2. Agents Actions 1992;Spec:C79-81.
6. Wallace JL, Whittle B J, Boughton-Smith NK. Prostaglandin protection of rat colonic mucosa from damage induced by ethanol. Dig Dis Sci 1985;30:866-76.
7. Tessner TG, Cohn SM, Schloemann S, Stenson WF. Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. Gastroenterology 1998; 115: 874-82.
8. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
9. Yoshizumi M, Sasaki S, Hirata I, Katsu K. The investigation on the mechanism of mucosal injury in DSS-induced colitis: With emphasis on free radical and cytokine. Prog Med 1996; 16:2483-7 (in Japanese).
10. Sasaki S, Hirata I, Maemura K et al. Prostaglandin E2 inhibits lesion formation in dextran sodium sulphate-induced colitis in rats and reduces the levels of mucosal inflammatory cytokines. Scand J Immunol 2000;51:23-8.
11. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14:157-67.
12. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994;55:97-179.
13. Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996;38:216-22.
14. Kishimoto S, Haruma K, Tari A, Sakurai K, Nakano M, Nakagawa Y. Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats. Dig Dis Sci 2000;45:1608-16.
15. Mazzucchelli L, Hauser C, Zgraggen K et al. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 1994; 144: 997-1007.
16. Pedersen G, Saermark T, Bendtzen K, Brynskov J. Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFNgamma, TNFalpha and IL-lbeta on viability, butyrate oxidation and IL-8 secretion. Autoimmunity 2000;32:255-63.
17. Bocker U, Schottelius A, Watson JM et al. Cellular differentiation causes a selective down-regulation of interleukin (IL)l beta-mediated NF-kappaB activation and IL-8 gene expression in intestinal epithelial cells. J Biol Chem 2000;275: 12207-13.
18. Reinecker HC, Steffen M, Witthoeft T et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94: 174-81.
19. Shintani N, Nakajima T, Nakakubo H et al. Intravenous immunoglobulin (IVIG) treatment of experimental colitis induced by dextran sulfate sodium in rats. Clin Exp Immunol 1997;108:340-5.
20. Mauel J, Ransijn A, Corradin SB, Buchmuller-Rouiller Y. Effect of PGE2 and of agents that raise cAMP levels on macrophage activation induced by IFN-gamma and TNF-alpha. J Leukoc Biol 1995;58:217-24.
21. Zhong WW, Burke PA, Drotar ME, Chavali SR, Forse RA. Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunology 1995;84:446-52.
22. Strassmann G, Patil-Koota V, Finkelman F, Fong M, Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med 1994;180:2365-70.
23. Betz M, Fox BS. Prostaglandin E2 inhibits production of Thl lymphokines but not of Th2 lymphokines. J Immunol 1991;146: 108-13.
24. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:205-29.
25. Coleman RA, Grix SP, Head SA, Louttit JB, Mallett A, Sheldrick RL. A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 1994;47:151-68.
26. Ichikawa A, Sugimoto Y, Negishi M. Molecular aspects of the structures and functions of the prostaglandin E receptors. J Lipid Mediat Cell Signal 1996;14:83-7.
27. Honda A, Sugimoto Y, Namba T et al. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J Biol Chem 1993;268:7759-62.
28. Arakawa T, Laneuville O, Miller CA et al. Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells. Structure and expression of the murine prostaglandin EP4 receptor gene. J Biol Chem 1996;271:29569-75.
29. Katsuyama M, Ikegami R, Karahashi H, Amano F, Sugimoto Y, Ichikawa A. Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1 Biochem Biophys Res Commun 1998;251:727-31.
30. Yamane H, Sugimoto Y, Tanaka S, Ichikawa A. Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. Biochem Biophys Res Commun 2000;278: 224-8.
31. Ikegami R, Sugimoto Y, Segi E et al. The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages. J Immunol 2001 ;166:4689-96.
32. Nataraj C, Thomas DW, Tilley SL et al. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest 2001;108:1229-35.
33. Kunikata T, Araki H, Takeeda M, Kato S, Takeuchi K. Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes. J Physiol Paris 2001;95:157-63.
34. Yamamoto H, Maruyama T, Sakata K et al. Novel four selective agonists for prostaglandin E receptor subtypes [Abstract]. The 6th International Eicosanoid Conference, The Westin, Boston, MA, USA, 1999;152.
35. Mori K, Tanaka I, Kotani Met al. Gene expression of the human prostaglandin E receptor EP4 subtype: Differential regulation in monocytoid and lymphoid lineage cells by phorbol ester. J Mol Med 1996;74:333-6.
36. Robert A. Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prostaglandin Thromb Res 1976;2:507-20.
37. Racusen LC, Binder HJ. Effect of prostaglandin on ion transport across isolated colonic mucosa. Dig Dis Sci 1980;25:900-4.
38. Belley A, Chadee K. Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor. Gastroenterology 1999;117:1352-62.
39. + lymphocyte-associated Th2-type immune response in the intestine. J Immunol 2000; 164:6303-12.
40. Powrie F. T cells in inflammatory bowel disease: Protective and pathogenic roles. Immunity 1995;3:171-4.
41. Strober W, Kelsall B, Fuss Iet al. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 1997;18:61-4.
42. Newberry RD, Stenson WF, Lorenz RG. Cyclooxygenase-2dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 1999;5:900-6.
43. Braunstein J, Qiao L, Autschbach F, Schumann G, Meuer S. T cells of the human intestinal lamina propria are high producers of interleukin-10. Gut 1997;41:215-20.
44. Bogdan C, Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin10. Ann N Y Acad Sci 1993;685:713-39.
45. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994;56:1-26.
46. Matsuura T, West GA, Youngman KR, Klein JS, Fiocchi C. Immune activation genes in inflammatory bowel disease. Gastroenterology 1993;104:448-58.
47. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42.
48. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.